Michael M. Levitt

414 total citations
13 papers, 189 citations indexed

About

Michael M. Levitt is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Michael M. Levitt has authored 13 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Cancer Research. Recurrent topics in Michael M. Levitt's work include Glioma Diagnosis and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Michael M. Levitt is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Michael M. Levitt collaborates with scholars based in United States, Germany and Finland. Michael M. Levitt's co-authors include Rosa Hendler, E. R. Nadel, Philip Felig, Dunner Dl, Fieve Rr, Samuel K. McBrayer, William H. Hicks, Kimmo J. Hatanpaa, Yi Xiao and Samuel Barnett and has published in prestigious journals such as Medicine & Science in Sports & Exercise, International Journal of Radiation Oncology*Biology*Physics and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Michael M. Levitt

10 papers receiving 170 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael M. Levitt United States 4 86 41 41 38 24 13 189
Seongkyun Lim United States 11 197 2.3× 226 5.5× 36 0.9× 15 0.4× 29 1.2× 19 312
Michael Petr Denmark 8 74 0.9× 141 3.4× 17 0.4× 17 0.4× 23 1.0× 10 276
Kulandaivelu Mahalingam India 8 60 0.7× 150 3.7× 10 0.2× 20 0.5× 77 3.2× 11 301
Heiko Brennenstuhl Germany 11 30 0.3× 180 4.4× 19 0.5× 16 0.4× 12 0.5× 25 315
Elles van der Louw Netherlands 10 337 3.9× 120 2.9× 14 0.3× 35 0.9× 40 1.7× 20 416
Amy N. Hicks United States 5 14 0.2× 100 2.4× 11 0.3× 15 0.4× 11 0.5× 7 176
Pascal Gottmann Germany 10 83 1.0× 148 3.6× 27 0.7× 11 0.3× 62 2.6× 24 309
David T. Broome United States 8 41 0.5× 92 2.2× 13 0.3× 8 0.2× 10 0.4× 23 258
Magalie Barth France 12 92 1.1× 274 6.7× 29 0.7× 8 0.2× 22 0.9× 32 378
Giuseppe Ribizzi Italy 6 75 0.9× 78 1.9× 28 0.7× 4 0.1× 3 0.1× 10 276

Countries citing papers authored by Michael M. Levitt

Since Specialization
Citations

This map shows the geographic impact of Michael M. Levitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Levitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Levitt more than expected).

Fields of papers citing papers by Michael M. Levitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. Levitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Levitt. The network helps show where Michael M. Levitt may publish in the future.

Co-authorship network of co-authors of Michael M. Levitt

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M. Levitt. A scholar is included among the top collaborators of Michael M. Levitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M. Levitt. Michael M. Levitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ray, Anish, et al.. (2024). Precision Medicine for Acute Lymphoblastic Leukemia in Children: A Review. Children. 11(11). 1329–1329.
2.
Myllykoski, Matti, John Z. Cao, Bill H. Diplas, et al.. (2023). (R) -2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH -Mutant Cancers. Cancer Discovery. 13(6). 1478–1497. 22 indexed citations
3.
Hamby, Tyler, et al.. (2023). Proactive Glucose Screening Tool Effective for Time-sensitive Identification of Hyperglycemia in Childhood Cancer Patients. Journal of Pediatric Hematology/Oncology. 45(6). e695–e701. 1 indexed citations
4.
Bird, Cylaina, Milan R. Savani, William H. Hicks, et al.. (2022). Semi-Automated Computational Assessment of Cancer Organoid Viability Using Rapid Live-Cell Microscopy. Cancer Informatics. 21. 2663727314–2663727314. 2 indexed citations
5.
Gao, Wenhua, Januka Khanal, Michael M. Levitt, et al.. (2021). Identification of De Novo Pyrimidine Synthesis as a Targetable Vulnerability in a Novel IDH1 Mutant Engineered Astrocytoma Model. International Journal of Radiation Oncology*Biology*Physics. 111(3). S86–S86. 2 indexed citations
6.
Shi, Diana D., Michael M. Levitt, Jennifer E. Endress, et al.. (2021). DDRE-29. DE NOVO PYRIMIDINE SYNTHESIS IS A TARGETABLE VULNERABILITY IN IDH-MUTANT GLIOMA. Neuro-Oncology Advances. 3(Supplement_1). i12–i13. 1 indexed citations
7.
Abdullah, Kalil G., Cylaina Bird, Milan R. Savani, et al.. (2021). Establishment of patient-derived organoid models of lower-grade glioma. Neuro-Oncology. 24(4). 612–623. 48 indexed citations
8.
Abdullah, Kalil G., Cylaina Bird, Milan R. Savani, et al.. (2021). TMOD-06. CREATION OF PATIENT-DERIVED LOWER GRADE GLIOMA ORGANOID MODELS FOR PERSONALIZED TREATMENT RESPONSE ASSESSMENT. Neuro-Oncology. 23(Supplement_6). vi216–vi217.
9.
Shi, Diana D., Adam Wang, Wenhua Gao, et al.. (2020). TMOD-14. CREATION OF A GENETICALLY ENGINEERED MOUSE MODEL OF ANAPLASTIC ASTROCYTOMA DRIVEN BY THE IDH1-R132H ONCOGENE. Neuro-Oncology. 22(Supplement_2). ii230–ii231. 1 indexed citations
10.
Bates, Lauren, et al.. (2020). Mucosal-Associated Invariant T Cell Response To Acute Exercise In Overweight Older Women. Medicine & Science in Sports & Exercise. 52(7S). 664–664. 1 indexed citations
11.
Cardenas, Maria A., et al.. (2018). Exercise-Induced Th17 Lymphocyte Response and Their Relationship to Cardiovascular Disease Risk Factors in Obese, Post-Menopausal Women. TopSCHOLAR (Western Kentucky University). 2(10). 13.
12.
Felig, Philip, et al.. (1983). Energy expenditure in obesity in fasting and postprandial state. American Journal of Physiology-Endocrinology and Metabolism. 244(1). E45–E51. 89 indexed citations
13.
Dl, Dunner, et al.. (1977). Erythrocyte catechol-o-methyltransferase activity in primary affective disorder.. PubMed. 12(2). 237–44. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seongkyun Lim Breakdown of academic impact, for papers by Michael Petr Breakdown of academic impact, for papers by Kulandaivelu Mahalingam Breakdown of academic impact, for papers by Heiko Brennenstuhl Breakdown of academic impact, for papers by Elles van der Louw Breakdown of academic impact, for papers by Amy N. Hicks Breakdown of academic impact, for papers by Pascal Gottmann Breakdown of academic impact, for papers by David T. Broome Breakdown of academic impact, for papers by Magalie Barth Breakdown of academic impact, for papers by Giuseppe Ribizzi
Rankless by CCL
2026